Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 12th September 2022
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

David Rendle appointed new BEVA president
New BEVA President David Rendle (left) with former President Huw Griffiths.

The ceremony took place during the association’s annual congress.

Equine medicine and therapeutics consultant Dr David Rendle has been appointed as president of the British Equine Veterinary Association (BEVA) for 2022/23.

Dr Rendle took over the reins from Huw Griffiths during the Association’s annual congress in Liverpool (7-10 September). He will be supported by the new president-elect, Roger Smith.

David said that he will use his presidential year to build on his recent work around antimicrobial and anthelmintic resistance as well as expanding BEVA’s global outreach to support more equine vets and have a greater impact on equine welfare. 

He said: “I’ve had a great time being part of the profession for the past 20 years and I am now in a position to give something back. Huw has driven much activity in the past year around recruitment and retention and I hope to be able to build on this and action results from the recent survey, under Huw’s continued supervision.

"I am also determined to maintain momentum around BEVA’s antimicrobial and anthelmintic resistance work as well as step up collaboration internationally on these and other projects to extend BEVA’s global outreach ".

A graduate of the University of Bristol, David has extensive experience in farm animal and equine practice. 

He trained as a specialist in equine internal medicine, earned a masters via research on equine asthma, and achieved an RCVS certificate in equine medicine during a three-year Horserace Betting Levy Board residency at The University of Glasgow and Liphook Equine Hospital.

Dr Rendle spent time at The Royal Veterinary College, London, and Charles Sturt University in Australia before moving to Rainbow Equine Hospital in Yorkshire, where he led the internal medicine and laboratory services as a director and subsequently a clinical director. 

He now combines work as an independent equine medicine and therapeutics consultant with running the family farm on the edge of Exmoor. He is chair of BEVA’s health and medicines committee. 

David added: “Around 99 per cent of the world’s horses are cared for by around one per cent of the world’s vets so we are not going to change things overnight; however, BEVA has so much to offer and we should use our resources to support equine welfare, irrespective of where equine vets and their patients live and work".

Image (C) BEVA.

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.